Ensuring quality control in a COVID-19 clinical trial during the pandemic: The experience of the Inserm C20–15 DisCoVeRy study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ensuring quality control in a COVID-19 clinical trial during the pandemic: The experience of the Inserm C20–15 DisCoVeRy study

Published:2023-08 Issue: Volume:131 Page:107267
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Fougerou-Leurent Claire,Delmas Christelle,Saillard Juliette,Dumousseaux Marina,Ferrane Assia,Mercier Noémie,Terzic Vida,Le Mestre Soizic,Dechanet Aline,Belhadi Drifa,Metois Annabelle,Burdet Charles,Mentré France,Noret Marion,Diallo Alpha,Petrov-Sanchez Ventzislava,Couffin-Cadiergues Sandrine,Hites Maya,Ader Florence,Esperou Hélène

Funder

Belgian Health Care Knowledge Centre

Fonds Erasme

European Union

Île-de-France Regional Council

French Government Ministry of Social Affairs Health and Womens Rights

European Regional Development Fund

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference28 articles.

1. A novel coronavirus from patients with pneumonia in China, 2019;Zhu;N. Engl. J. Med.,2020

2. Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults;Ader;BMJ Open,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP